Leon Perel, MD
Pain Medicine · Las Vegas, NVNPI 1871754572
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Abbott at 59.7% of the total. That places this record below the midpoint for pain medicine clinicians in NV, where the typical reported total is $2,557.
Across 74 payments — averaging $38.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Vertiflex, Inc.$855
- Boston Scientific$130
- Curonix LLC$75
- Orexo US, Inc.$72
- Biodelivery Sciences International, Inc.$27
What the payments were for
- Consulting fees$65023%
- Travel & lodging$70224%
- Food & beverage$1,52553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 57 | $1,717 |
| Vertiflex, Inc. | 5 | $855 |
| Boston Scientific | 2 | $130 |
| Curonix LLC | 4 | $75 |
| Orexo US, Inc. | 4 | $72 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,876 in reported general payments places this provider in the 50th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 277 | $2,716 |
| Buprenorphine | 12 | $1,887 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 63 | $1,872 |
| Lidocaine | 16 | $1,652 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $1,606 |
| Pregabalin | 129 | $1,580 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $1,083 |
| Methocarbamol | 120 | $1,055 |
| Diclofenac Sodium | 92 | $997 |
| Cephalexin | 58 | $624 |
| Duloxetine Hcl | 33 | $532 |
| Tramadol Hcl | 41 | $478 |
| Morphine Sulfate ErMorphine Sulfate | 21 | $427 |
| Oxycodone Hcl | 26 | $395 |
| Tizanidine Hcl | 31 | $338 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Neville CampbellLas Vegas$11K
- Heerak KangLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.